Navigation Links
Penn Medicine's Daniel J. Rader, M.D., receives AHA's Clinical Research Prize
Date:11/5/2012

LOS ANGELES - Daniel J. Rader, MD, professor of Medicine and chief, Division of Translational Medicine and Human Genetics at the Perelman School of Medicine at the University of Pennsylvania, has been awarded the American Heart Association's (AHA) Clinical Research Prize for developing new methods to identify factors regulating the metabolism of fat particles in the bloodstream and testing their impact on the development of atherosclerosis. Dr. Rader received the award today during the opening ceremony of the AHA Scientific Sessions in Los Angeles, CA.

Dr. Rader has spent the last two decades working in the field of lipoprotein biology and atherosclerosis, and is a widely recognized international leader in this field. His basic research laboratory focuses on genetic and pharmacologic regulation of lipoprotein metabolism and atherosclerosis, and he directs a translational research program focusing on new pathways involved in lipoprotein metabolism and atherosclerosis discovered through human genetics studies and novel approaches to treatment of dyslipidemia and atherosclerotic cardiovascular disease.

Dr. Rader has a particular interest in the metabolism of HDL (the "good cholesterol") and its relationship to atherosclerosis. In recent research, he has illuminated pathways of HDL-mediated 'reverse cholesterol transport' and has shown that the functional ability of HDL to extract cholesterol from cells is a better predictor of coronary disease than HDL cholesterol blood levels. In addition, Rader and his team have helped to understand how new genes associated with dyslipidemia and coronary artery disease work to influence these conditions. Finally, Rader and his team demonstrated the potential usefulness of a drug that works through a new pathway to lower LDL (the "bad cholesterol") in patients with a severe form of inherited high cholesterol.

He is a Distinguished Fellow of the International Atherosclerosis Society, a member of the Board of External Experts of the National Heart, Lung, and Blood Institute (NHLBI), and a member of the Institute of Medicine.


'/>"/>
Contact: Jessica Mikulski
jessica.mikulski@uphs.upenn.edu
215-796-4829
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
2. DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines
3. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
4. Nearly 1 in 4 grandparents store prescription medicines where children can easily find them
5. Nanomedicines promise fewer side effects in treating cancer
6. New technology represents next-generation tool for detecting substandard and counterfeit medicines
7. New research reveals extent of poor-quality antimalarial medicines in South American countries
8. Toward medicines that recruit the bodys natural disease-fighting proteins
9. Strategy developed to improve delivery of medicines to the brain
10. Popular pain-relieving medicines linked to hearing loss in women
11. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: